|
|
|
Insider
Information: |
Lisicki Robert |
Relationship: |
EVP, Chief Commercial ... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Arena Pharmaceuticals Inc |
ARNA |
EVP, Chief Commercial ... |
2022-03-11 |
0 |
2019-10-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2022-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(37,563) |
0 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
21,462 |
37,563 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2021-08-03 |
4 |
AS |
$59.84 |
$1,051,482 |
D/D |
(17,500) |
16,101 |
0 |
% |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2021-08-03 |
4 |
OE |
$40.95 |
$716,625 |
D/D |
17,500 |
33,601 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,660 |
16,101 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2021-02-02 |
4 |
AS |
$77.70 |
$1,380,308 |
D/D |
(17,500) |
9,441 |
0 |
% |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2021-02-02 |
4 |
OE |
$40.95 |
$716,625 |
D/D |
17,500 |
26,941 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2021-01-07 |
4 |
D |
$77.59 |
$245,107 |
D/D |
(3,159) |
9,441 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2021-01-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,600 |
12,600 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2020-12-01 |
4 |
S |
$64.87 |
$255,786 |
D/D |
(3,872) |
0 |
0 |
% |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2020-11-25 |
4 |
D |
$65.50 |
$159,034 |
D/D |
(2,428) |
3,872 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2020-11-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,300 |
6,300 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2020-08-04 |
4 |
AS |
$62.63 |
$1,900,345 |
D/D |
(30,000) |
0 |
0 |
% |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2020-08-04 |
4 |
OE |
$40.95 |
$1,228,500 |
D/D |
30,000 |
30,000 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2019-11-13 |
4 |
S |
$45.83 |
$203,000 |
D/D |
(4,429) |
0 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2019-10-14 |
4 |
D |
$47.32 |
$88,536 |
D/D |
(1,871) |
4,429 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP, Chief Commercial Officer |
|
2019-10-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,300 |
6,300 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|